Physicians often fail to counsel recovering heart attack patients on whether they are at risk of having another myocardial infarction triggered by sexual activity. In a letter to the Journal of the American College of Cardiology, Dietrich Rothenbacher, MD, MPH and colleagues have reassuring data.
The link between testosterone therapy and cardiovascular risks has been a hot topic of debate, with researchers offering competing evidence and statements supporting or refuting the existence of link between testosterone supplementation and increased cardiovascular risk. Now, physicians from the American Association of Clinical Endocrinologists (AACE) have publicly stated their position on the issue.
Precision medicine’s role in the management of hypogonadism is still in its formative stages. Researchers suggest that identifying biomarkers associated with individual patients’ treatment responses is possible.
The Food and Drug Administration (FDA) is requiring additional clinical trials on testosterone supplements after revealing that labeling claims about their safety and efficacy are not backed by substantial evidence.
At least 5 studies indicating that testosterone replacement therapy either has no effect on cardiovascular health -- or tends to improve it -- appeared during the 3-week period immediately after the US Food and Drug Administration's controversial decision to mandate warnings about the potential cardiovascular risks of such treatment.
Researchers have long known that single men tend to have more testosterone than comparable men in long-term relationships, but what about men in new relationships? A new study finds that testosterone generally remains at “single-man” levels until couples have been dating for more than a year.